Global Pleural Effusions Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Pleural Effusions Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Pleural effusions treatment includes medical procedures and interventions used to manage the accumulation of fluid in the pleural space around the lungs.
Global Pleural Effusions Treatment market is projected to reach US$ 2474.1 million in 2029, increasing from US$ 1522.7 million in 2022, with the CAGR of 7.1% during the period of 2024 to 2029. Demand from Hospitals and Clinics are the major drivers for the industry.
The market for pleural effusions treatment is driven by the demand for effective and minimally invasive procedures to drain and manage pleural fluid build-up. The market's growth is also influenced by the increasing prevalence of pleural effusions in various medical conditions, such as congestive heart failure and cancer.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pleural Effusions Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report

B. Braun
Nouvag
Oakworks Medical
Heyer Medical
Smith Medical
Biometrix
Maxer
Redax
Bicakcilar
Grena
Shyndec Pharmaceutical
Lepu Medical
Balance Medical
Segment by Type
Thoracentesis
Pleurodesis
Pleuroperitoneal Shunt
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pleural Effusions Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Pleural Effusions Treatment introduction, etc. Pleural Effusions Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Pleural Effusions Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Global Pleural Effusions Treatment market is projected to reach US$ 2474.1 million in 2029, increasing from US$ 1522.7 million in 2022, with the CAGR of 7.1% during the period of 2024 to 2029. Demand from Hospitals and Clinics are the major drivers for the industry.
The market for pleural effusions treatment is driven by the demand for effective and minimally invasive procedures to drain and manage pleural fluid build-up. The market's growth is also influenced by the increasing prevalence of pleural effusions in various medical conditions, such as congestive heart failure and cancer.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pleural Effusions Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report

By Company
B. Braun
Nouvag
Oakworks Medical
Heyer Medical
Smith Medical
Biometrix
Maxer
Redax
Bicakcilar
Grena
Shyndec Pharmaceutical
Lepu Medical
Balance Medical
Segment by Type
Thoracentesis
Pleurodesis
Pleuroperitoneal Shunt
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pleural Effusions Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Pleural Effusions Treatment introduction, etc. Pleural Effusions Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Pleural Effusions Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
